Surgical cytoreduction for recurrent epithelial ovarian cancer, Cochrane Database Syst Rev, vol.2, p.8765, 2013. ,
???Optimal??? cytoreduction for advanced epithelial ovarian cancer: A commentary, Gynecologic Oncology, vol.103, issue.1, pp.329-364, 2006. ,
DOI : 10.1016/j.ygyno.2006.07.004
Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer, European Journal of Cancer, vol.47, issue.3, pp.88-92, 2011. ,
DOI : 10.1016/S0959-8049(11)70152-6
Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases, European Journal of Cancer, vol.50, issue.2, 2013. ,
DOI : 10.1016/j.ejca.2013.09.024
Photodynamic therapy of cancer: An update, CA: A Cancer Journal for Clinicians, vol.4, issue.1, pp.250-81, 2011. ,
DOI : 10.3322/caac.20114
Evaluation of ALA- PDT of ovarian cancer in the Fisher 344 rat tumor model. Photodiagnosis PhotodynTher, pp.254-60, 2007. ,
Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy, Bioorganic & Medicinal Chemistry, vol.13, issue.8, 2005. ,
DOI : 10.1016/j.bmc.2005.02.025
URL : https://hal.archives-ouvertes.fr/hal-00200165
-tetra(Hydroxyphenyl)chlorin-Like Photosensitizer Selectivity with Folate-Based Targeted Delivery. Synthesis and in Vivo Delivery Studies, Journal of Medicinal Chemistry, vol.51, issue.13, pp.3867-77, 2008. ,
DOI : 10.1021/jm800125a
URL : https://hal.archives-ouvertes.fr/hal-00758622
Folate-targeted PEGylated liposomes improve the selectivity of PDT with meta-tetra(hydroxyphenyl)chlorin (m-THPC), Photochemical & Photobiological Sciences, vol.7, issue.5, p.823, 2013. ,
DOI : 10.1039/c3pp25384h
A novel chlorin???PEG???folate conjugate with higher water solubility, lower cytotoxicity, better tumor targeting and photodynamic activity, Journal of Photochemistry and Photobiology B: Biology, vol.127, pp.28-37, 2009. ,
DOI : 10.1016/j.jphotobiol.2013.06.008
Folate and Carcinogenesis: An Integrated Scheme, J Nutr, 2000. ,
Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy, Gynecologic Oncology, vol.130, issue.1, pp.192-201, 2013. ,
DOI : 10.1016/j.ygyno.2013.03.024
Folate Receptors, Annual Review of Nutrition, vol.16, issue.1, pp.501-522, 1996. ,
DOI : 10.1146/annurev.nu.16.070196.002441
Folate-mediated targeting: from diagnostics to drug and gene delivery, Drug Discovery Today, vol.6, issue.1, pp.44-51, 2001. ,
DOI : 10.1016/S1359-6446(00)01594-4
Targeted drug delivery via the folate receptor, Advanced Drug Delivery Reviews, vol.41, issue.2, pp.147-62, 2000. ,
DOI : 10.1016/S0169-409X(99)00062-9
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay, Analytical Biochemistry, vol.338, issue.2, pp.284-93, 2005. ,
DOI : 10.1016/j.ab.2004.12.026
Folate receptor alpha as a tumor target in epithelial ovarian cancer, Gynecologic Oncology, vol.108, issue.3, 2008. ,
DOI : 10.1016/j.ygyno.2007.11.020
Alpha-folate Receptor Expression in Epithelial Ovarian Carcinoma and Non-neoplastic Ovarian Tissue, Anticancer Res, vol.28, issue.6A, pp.3567-72, 2008. ,
Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy, Advanced Drug Delivery Reviews, vol.56, issue.8, pp.1067-84, 2004. ,
DOI : 10.1016/j.addr.2004.01.001
Expression of folate receptor-? (FRA) ,
The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer, CellOncol, 2011. ,
Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response, Molecular Oncology, vol.280, issue.2, pp.360-369, 2012. ,
DOI : 10.1016/j.molonc.2011.11.010
Overexpression of folate binding protein in ovarian cancers, International Journal of Cancer, vol.75, issue.2, pp.193-201, 1997. ,
DOI : 10.1002/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F
Paradoxical Impact of Two Folate Receptors, FR?? and RFC, in Ovarian Cancer: Effect on Cell Proliferation, Invasion and Clinical Outcome, PLoS ONE, vol.68, issue.11, p.47201, 2012. ,
DOI : 10.1371/journal.pone.0047201.t003
Gene Transfection and Expression of the Ovarian Carcinoma Marker Folate Binding Protein on NIH/3T3 Cells Increases Cell Growth in Vitro and in Vivo, Cancer Res, vol.53, issue.23, pp.5791-5797, 1993. ,
Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: A clinicopathologic study of 60 cases, Human Pathology, vol.28, issue.8, pp.922-930, 1997. ,
DOI : 10.1016/S0046-8177(97)90007-1
Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via ??5-Integrin, which Is a Therapeutic Target, Cancer Research, vol.68, issue.7, pp.2329-2368, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-5167
Impact of High and Low Folate Diets on Tissue Folate Receptor Levels and Antitumor Responses Toward Folate-Drug Conjugates, Journal of Pharmacology and Experimental Therapeutics, vol.327, issue.3, pp.918-943, 2008. ,
DOI : 10.1124/jpet.108.143206
Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis., Proceedings of the National Academy of Sciences, vol.88, issue.13, pp.5572-5578, 1991. ,
DOI : 10.1073/pnas.88.13.5572
Clinical trials and future potential of targeted therapy for ovarian cancer, International Journal of Clinical Oncology, vol.90, issue.5, pp.430-470, 2012. ,
DOI : 10.1007/s10147-012-0459-8
The role of folate receptor ?? in cancer development, progression and treatment: Cause, consequence or innocent bystander?, International Journal of Cancer, vol.257, issue.2, pp.243-50, 2006. ,
DOI : 10.1002/ijc.21712
Intraoperative imaging in ovarian cancer: fact or fiction? Mol Imaging, 2011. ,
Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis, Biomaterials, vol.32, issue.33, pp.8548-54, 2011. ,
DOI : 10.1016/j.biomaterials.2011.07.067
Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies, Gene Therapy, vol.10, issue.12, pp.1018-1043, 2003. ,
DOI : 10.1038/sj.gt.3301962
Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha Available from, Cancer Immun J Acad Cancer Immunol [Internet], vol.7, 2007. ,
PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer, J ClinOncol, 2013. ,
Gynaecological cancer: Vintafolide???targeting the folate receptor with a cytotoxic offers hope, Nature Reviews Clinical Oncology, vol.10, issue.12, p.668, 2013. ,
DOI : 10.1038/nrclinonc.2013.201